Furthermore, as expected, our secondary HLH patients demonstrated significant laboratory abnormalities, including cytopenias, markedly elevated inflammatory markers (CRP and ferritin), hypertriglyceridemia, and increased liver enzymes. The gene discussed is CRP; the disease is hemophagocytic syndrome.